6560 POSTER A Phase I Safety and Pharmacokinetic Study of Everolimus, an Oral mTOR Inhibitor, in Subjects With Impaired Hepatic Function
Peveling-Oberhag, J, Zeuzem, S, Yong, W.R, Kunz, T, Paquet, T, Bouillaud, E, Urva, S, Anak, O, Seilami, D, Kobalava, Z
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article